We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,976 hedge funds and large institutions have $198B invested in Johnson & Johnson in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 732 increasing their positions, 972 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

8% more capital invested

Capital invested by funds: $185B → $198B (+$13.9B)

2% more funds holding in top 10

Funds holding in top 10: 675688 (+13)

0.49% more ownership

Funds ownership: 66.51%67% (+0.49%)

0% more funds holding

Funds holding: 1,9731,976 (+3)

25% less repeat investments, than reductions

Existing positions increased: 732 | Existing positions reduced: 972

26% less call options, than puts

Call options by funds: $1.09B | Put options by funds: $1.48B

Holders
1,976
Holders Change
+3
Holders Change %
+0.15%
% of All Funds
56.77%
Holding in Top 10
688
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+1.93%
% of All Funds
19.76%
New
54
Increased
732
Reduced
972
Closed
41
Calls
$1.09B
Puts
$1.48B
Net Calls
-$385M
Net Calls Change
-$512M
Name Holding Trade Value Shares
Change
Change in
Stake
Jones Financial Companies
576
Jones Financial Companies
Missouri
$15M -$326K -3,224 -2%
BCM
577
Buckhead Capital Management
Georgia
$15M -$796K -7,875 -5%
PFM
578
Parsec Financial Management
North Carolina
$15M -$29.4K -291 -0.2%
CONA
579
Capital One National Association
New York
$15M +$1.09M +10,744 +8%
CC
580
Cornerstone Capital
California
$14.9M -$32.4K -321 -0.2%
RC
581
RegentAtlantic Capital
New Jersey
$14.9M -$42.9K -424 -0.3%
SAM
582
Strategy Asset Managers
California
$14.8M -$363K -3,592 -2%
KS
583
Karpas Strategies
Connecticut
$14.8M
WG
584
Welch Group
Alabama
$14.8M +$334K +3,309 +2%
CCT
585
Country Club Trust
Missouri
$14.8M +$133K +1,315 +0.9%
QAM
586
QCI Asset Management
New York
$14.8M -$372K -3,680 -3%
CPSAC
587
Chas P. Smith & Associates (CPS)
Florida
$14.7M -$27M -267,620 -66%
CIM
588
Corda Investment Management
Texas
$14.7M -$21K -208 -0.1%
STI
589
Susquehanna Trust & Investment
Pennsylvania
$14.6M -$677K -6,694 -5%
VAM
590
Visium Asset Management
New York
$14.6M -$12M -118,908 -46%
RJFSA
591
Raymond James Financial Services Advisors
Florida
$14.5M -$12.2K -121 -0.1%
WC
592
Woodstock Corp
Massachusetts
$14.5M -$12.2K -121 -0.1%
FFIC
593
First Fiduciary Investment Counsel
Ohio
$14.4M +$8.09K +80 +0.1%
LM
594
Lincluden Management
Ontario, Canada
$14.4M +$800K +7,910 +6%
FCI
595
Financial Counselors Inc
Kansas
$14.3M -$30.9K -306 -0.2%
MCTIC
596
MacGuire Cheswick & Tuttle Investment Counsel
Connecticut
$14.3M -$109K -1,082 -0.8%
CAM
597
Carret Asset Management
New York
$14.3M -$1.72M -16,968 -11%
KLWA
598
Kelly Lawrence W & Associates
California
$14.2M +$3.25M +32,200 +31%
BCM
599
Beddow Capital Management
Wyoming
$14.2M -$182K -1,800 -1%
WDA
600
Wendell David Associates
New Hampshire
$14.1M -$606 -6 -0%

JNJ Hedge Fund Activity: Q2 2014 in Review

1,976 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2014, worth a combined $198B — up 7.5% from $185B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new JNJ positions and 41 closed out — a net gain of 13 holders — while 732 added to existing stakes and 972 trimmed.

The largest buyer was Norges Bank, adding an estimated $2.09B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $331M.

  • 1,976 institutional investors held Johnson & Johnson (JNJ) as of Q2 2014, up from 1,973 in Q1 2014.
  • Funds reported $198B of Johnson & Johnson stock for Q2 2014, up 7.5% quarter-over-quarter.
  • 54 funds opened new Johnson & Johnson positions in Q2 2014 and 41 closed out, a net change of +13 holders.
  • The largest Johnson & Johnson buyer in Q2 2014 was Norges Bank, an estimated $2.09B added.
  • The largest Johnson & Johnson seller in Q2 2014 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $331M sold.

Based on aggregated 13F filings for Q2 2014.